Assay Development and Test Screen. Promptly following approval of a Work Plan (and in any event within ten (10) Business Days), AbCellera will initiate immunizations and assay development activities, and subsequently, when such activities are complete, run a test screen (collectively, “Preliminary Assessment”) to assess the likelihood of generating or identifying Hits and Leads for the relevant Lilly Target.
Appears in 2 contracts
Sources: Research Collaboration and License Agreement (AbCellera Biologics Inc.), Research Collaboration and License Agreement (AbCellera Biologics Inc.)